JP2009510170A5 - - Google Patents

Download PDF

Info

Publication number
JP2009510170A5
JP2009510170A5 JP2008534664A JP2008534664A JP2009510170A5 JP 2009510170 A5 JP2009510170 A5 JP 2009510170A5 JP 2008534664 A JP2008534664 A JP 2008534664A JP 2008534664 A JP2008534664 A JP 2008534664A JP 2009510170 A5 JP2009510170 A5 JP 2009510170A5
Authority
JP
Japan
Prior art keywords
phenyl
pyrimidine
carboxylic acid
benzylamide
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008534664A
Other languages
English (en)
Japanese (ja)
Other versions
JP5452925B2 (ja
JP2009510170A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/038841 external-priority patent/WO2007041634A1/en
Publication of JP2009510170A publication Critical patent/JP2009510170A/ja
Publication of JP2009510170A5 publication Critical patent/JP2009510170A5/ja
Application granted granted Critical
Publication of JP5452925B2 publication Critical patent/JP5452925B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008534664A 2005-10-04 2006-10-04 Pgds阻害剤としてのピリミジンアミド化合物 Active JP5452925B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72357005P 2005-10-04 2005-10-04
US60/723,570 2005-10-04
PCT/US2006/038841 WO2007041634A1 (en) 2005-10-04 2006-10-04 Pyrimidine amide compounds as pgds inhibitors

Publications (3)

Publication Number Publication Date
JP2009510170A JP2009510170A (ja) 2009-03-12
JP2009510170A5 true JP2009510170A5 (cg-RX-API-DMAC7.html) 2009-11-19
JP5452925B2 JP5452925B2 (ja) 2014-03-26

Family

ID=37635758

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008534664A Active JP5452925B2 (ja) 2005-10-04 2006-10-04 Pgds阻害剤としてのピリミジンアミド化合物

Country Status (27)

Country Link
US (1) US8202863B2 (cg-RX-API-DMAC7.html)
EP (1) EP1937652B1 (cg-RX-API-DMAC7.html)
JP (1) JP5452925B2 (cg-RX-API-DMAC7.html)
KR (1) KR101457966B1 (cg-RX-API-DMAC7.html)
CN (2) CN101538246B (cg-RX-API-DMAC7.html)
AR (1) AR056871A1 (cg-RX-API-DMAC7.html)
AU (1) AU2006299428B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0616815A2 (cg-RX-API-DMAC7.html)
CA (1) CA2624749C (cg-RX-API-DMAC7.html)
CR (1) CR9832A (cg-RX-API-DMAC7.html)
DO (1) DOP2006000210A (cg-RX-API-DMAC7.html)
EC (1) ECSP088335A (cg-RX-API-DMAC7.html)
ES (1) ES2514471T3 (cg-RX-API-DMAC7.html)
IL (1) IL190411A (cg-RX-API-DMAC7.html)
MA (1) MA29925B1 (cg-RX-API-DMAC7.html)
MY (1) MY151172A (cg-RX-API-DMAC7.html)
NO (1) NO20082000L (cg-RX-API-DMAC7.html)
NZ (1) NZ567208A (cg-RX-API-DMAC7.html)
PE (2) PE20110118A1 (cg-RX-API-DMAC7.html)
RU (1) RU2420519C2 (cg-RX-API-DMAC7.html)
SG (1) SG166121A1 (cg-RX-API-DMAC7.html)
TN (1) TNSN08104A1 (cg-RX-API-DMAC7.html)
TW (1) TWI415839B (cg-RX-API-DMAC7.html)
UA (1) UA93213C2 (cg-RX-API-DMAC7.html)
UY (1) UY29840A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007041634A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200802222B (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7759350B2 (en) * 2005-09-15 2010-07-20 Orchid Research Laboratories Ltd. Pyrimidine carboxamides
DOP2006000210A (es) 2005-10-04 2007-06-15 Aventis Pharma Inc Compuestos de pirimidina amida como inhibidores de pgds
MX2008013194A (es) 2006-04-11 2008-12-01 Vertex Pharma Composiciones utiles como inhibidores de canales de sodio regulados por voltaje.
CA2672373C (en) 2006-12-19 2011-08-30 Pfizer Products Inc. Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
JP2010519328A (ja) 2007-02-26 2010-06-03 ファイザー・プロダクツ・インク H−pgdsの阻害剤としてのニコチンアミド誘導体およびプロスタグランジンd2が媒介する疾患の治療のためのそれらの使用
ES2748599T3 (es) 2007-08-27 2020-03-17 Dart Neuroscience Cayman Ltd Compuestos terapéuticos de isoxazol
US8779197B2 (en) 2007-10-11 2014-07-15 Vertex Pharmaceuticals Incorporated Aryl amides useful as inhibitors of voltage-gated sodium channels
WO2009049181A1 (en) 2007-10-11 2009-04-16 Vertex Pharmaceuticals Incorporated Amides useful as inhibitors of voltage-gated sodium channels
US8519137B2 (en) 2007-10-11 2013-08-27 Vertex Pharmaceuticals Incorporated Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
CA2703220A1 (en) * 2007-11-13 2009-05-22 Pfizer Global Research And Development Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
ES2528129T3 (es) * 2008-02-06 2015-02-04 Msd K.K. Derivado de sulfonil piperacina sustituido en la posición 3
AU2009246446B2 (en) * 2008-05-13 2014-06-26 Cayman Chemical Company, Incorporated Methods for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin D synthase
CA2724998A1 (en) 2008-06-18 2009-12-23 Pfizer Limited Nicotinamide derivatives
JP2011524894A (ja) 2008-06-18 2011-09-08 ファイザー・リミテッド ニコチンアミド誘導体
AP3272A (en) 2008-09-22 2015-05-31 Cayman Chem Co Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prosaglandin D2 mediated diseases
KR101367057B1 (ko) 2009-03-17 2014-02-25 (주)아모레퍼시픽 피부 자극 완화용 조성물
WO2010056044A2 (ko) * 2008-11-11 2010-05-20 (주)아모레퍼시픽 바닐로이드 수용체 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염 및 이를 포함하는 약학 조성물
KR101252335B1 (ko) 2009-07-16 2013-04-08 (주)아모레퍼시픽 피부 노화 방지용 조성물
RU2496778C2 (ru) 2009-03-09 2013-10-27 Тайхо Фармасьютикал Ко., Лтд. Пиперазиновое соединение, ингибирующее простагландин-d-синтазу
PH12012501385A1 (en) 2010-01-22 2014-10-22 Taiho Pharmaceutical Co Ltd Piperazine compound having a pgds inhibitory effect
US9320723B2 (en) * 2010-05-03 2016-04-26 University Of Rochester Methods of treating thyroid eye disease
US9199976B2 (en) 2010-06-01 2015-12-01 The University Of Queensland Haematopoietic-prostaglandin D2 synthase inhibitors
CN106943407A (zh) * 2010-07-26 2017-07-14 赛诺菲 苯基噁二唑衍生物在制备治疗变应性或炎性疾病的药物中的用途
TW201217335A (en) 2010-09-07 2012-05-01 Taiho Pharmaceutical Co Ltd Prostaglandin d synthase inhibitory piperidine compounds
KR101271223B1 (ko) 2011-01-27 2013-06-07 한국과학기술연구원 아미노피리미딘 유도체 및 이를 포함하는 세포외 신호조절 키나제의 제해제
EP2800568A4 (en) * 2012-01-06 2015-06-10 Univ South Florida COMPOSITIONS, USE METHOD AND TREATMENT METHOD THEREFOR
ES2640049T3 (es) * 2012-08-24 2017-10-31 Sunshine Lake Pharma Co., Ltd. Derivados de 3,6-dihidropirimidina 2,4,5,6-sustituidos como inhibidores de la polimerasa del virus de la hepatitis B (VHB) para el tratamiento de, por ejemplo, la hepatitis crónica
WO2017103851A1 (en) 2015-12-17 2017-06-22 Astex Therapeutics Limited Quinoline-3-carboxamides as h-pgds inhibitors
US10669270B2 (en) * 2016-03-14 2020-06-02 Emory University Amide-sulfamide derivatives, compositions, and uses related to CXCR4 inhibition
JOP20190072A1 (ar) * 2016-10-13 2019-04-07 Glaxosmithkline Ip Dev Ltd مشتقات 1، 3 سيكلوبوتان ثنائي الاستبدال أو آزيتيدين كمثبطات للإنزيم المخلق للبروستاجلاندين d المكون للدم
CA3066979A1 (en) 2017-06-13 2018-12-20 Glaxosmithkline Intellectual Property Development Limited Chemical compounds as h-pgds inhibitors
US11357759B2 (en) 2017-10-29 2022-06-14 China Medical University Composition including ADAM9 inhibitor and the use thereof
CN111479814A (zh) 2017-12-13 2020-07-31 葛兰素史密斯克莱知识产权发展有限公司 作为h-pgds抑制剂的稠合的吡啶
IL277455B2 (en) * 2018-03-23 2024-05-01 Step Pharma S A S Aminopyrimidine derivatives as ctps1 inhibitors
BR112021008976A2 (pt) 2018-11-08 2021-08-03 Glaxosmithkline Intellectual Property Development Limited compostos químicos
AU2021272972A1 (en) * 2020-05-13 2022-12-08 Chdi Foundation, Inc. HTT modulators for treating Huntington's disease
WO2021256569A1 (ja) 2020-06-19 2021-12-23 佐藤製薬株式会社 H-pgdsを阻害する縮環化合物
US12331046B2 (en) * 2020-10-23 2025-06-17 Nimbus Clotho, Inc. CTPS1 inhibitors and uses thereof
CN113004208A (zh) * 2021-03-08 2021-06-22 沈阳药科大学 一种抑制黄嘌呤氧化酶活性的化合物及制备方法和应用
JP2024540477A (ja) * 2021-11-17 2024-10-31 シーエイチディーアイ ファウンデーション,インコーポレーテッド ハンチントン病を治療するためのhttモジュレータとしてのn-(2h-インダゾール-5-イル)ピラジン-2-カルボキサミド誘導体及び類似化合物
WO2023113023A1 (ja) 2021-12-17 2023-06-22 佐藤製薬株式会社 H-pgdsを阻害するアザインドール誘導体

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2934543A1 (de) * 1979-08-27 1981-04-02 Basf Ag, 6700 Ludwigshafen Substituierte n-benzoylanthranilsaeurederivate und deren anydroverbindungen, verfahren zu ihrer herstellung und ihre verwendung als herbizide
JPH03112985A (ja) * 1989-09-28 1991-05-14 Morishita Pharmaceut Co Ltd N―(1h―テトラゾール―5―イル)―2―フェニル―5―ピリミジンカルボキシアミド類及びその合成用中間体
GB9405347D0 (en) * 1994-03-18 1994-05-04 Agrevo Uk Ltd Fungicides
JP2000226372A (ja) * 1999-02-01 2000-08-15 Nippon Soda Co Ltd アミド化合物、その製造方法及び農園芸用殺虫剤
AU7315700A (en) * 1999-09-20 2001-04-24 Takeda Chemical Industries Ltd. Melanin concentrating hormone antagonist
JP2002003370A (ja) * 1999-09-20 2002-01-09 Takeda Chem Ind Ltd メラニン凝集ホルモン拮抗剤
MY138097A (en) * 2000-03-22 2009-04-30 Du Pont Insecticidal anthranilamides
JP2003112985A (ja) 2001-10-01 2003-04-18 Nre Happiness Kk 食品残渣肥、飼料原料化システムおよびそれに使用する破砕貯留処理ユニット並びに乾燥冷却処理ユニット
JPWO2004011430A1 (ja) * 2002-07-25 2005-11-24 アステラス製薬株式会社 ナトリウムチャネル阻害剤
DE60329513D1 (de) * 2002-07-30 2009-11-12 Banyu Pharma Co Ltd Antagonist des melanin-concentrating-hormone-rezeptors, enthaltend ein benzimidazolderivat als wirkstoff
DE602004024375D1 (de) * 2003-02-14 2010-01-14 Glaxo Group Ltd Carboxamidderivate
PT1471057E (pt) * 2003-04-25 2006-05-31 Actimis Pharmaceuticals Inc Derivados de acido pirimidinilacetico uteis para o tratamento de doencas mediadas por crth2
BRPI0415167A (pt) * 2003-10-07 2006-11-28 Renovis Inc composto de amina como ligandos de canal de ìon e usos dos mesmos
AU2005209257A1 (en) * 2004-01-23 2005-08-11 Amgen Inc. Vanilloid receptor ligands and their use in treatments
DOP2006000210A (es) 2005-10-04 2007-06-15 Aventis Pharma Inc Compuestos de pirimidina amida como inhibidores de pgds

Similar Documents

Publication Publication Date Title
JP2009510170A5 (cg-RX-API-DMAC7.html)
CA2624749A1 (en) Pyrimidine amide compounds as pgds inhibitors
KR101135310B1 (ko) L-cpt1 억제제로서의 헤테로아릴 치환된 피페리딘유도체
CN101952275B (zh) β-淀粉样蛋白的调节剂
CA2593439C (en) Thiazole-4-carboxamide derivatives as mglur5 antagonists
JP2006500348A5 (cg-RX-API-DMAC7.html)
JP2006511608A5 (cg-RX-API-DMAC7.html)
CA2550596A1 (en) 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
JP2008503497A5 (cg-RX-API-DMAC7.html)
CN1520296A (zh) 作为葡糖激酶(glk)调制剂的氨基烟酸盐衍生物
HRP20120589T1 (hr) Aktivatori glukokinaze pirolidinona
JP2010514677A5 (cg-RX-API-DMAC7.html)
CN1568185A (zh) 影响葡糖激酶的化合物
CA2588517A1 (en) 5-carboxamido substituted thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family
WO2004103980A1 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
JP2013517273A5 (cg-RX-API-DMAC7.html)
JP2015509510A5 (cg-RX-API-DMAC7.html)
ME02198B (me) Derivati ciklopentilakrilamida
RU2019122999A (ru) Новое соединение и его фармакологически приемлемая соль
JP2006500369A5 (cg-RX-API-DMAC7.html)
KR20070083939A (ko) 아릴옥시 치환된 벤즈이미다졸 유도체
TW201300380A (zh) 抑制β-分泌酶活性之噁二唑化合物及其使用方法
RU2415846C2 (ru) Производные, имеющие активность агонистов ppar-рецепторов
JP2008535863A5 (cg-RX-API-DMAC7.html)
RU2007129779A (ru) Новые соединения пиридина